Crijns HJ - Search Results

1

The presence of an atrial electromechanical delay in idiopathic atrial fibrillation as determined by tissue Doppler imaging.

Weijs B, de Vos CB, Limantoro I, Cheriex EC, Tieleman RG, Crijns HJ. Weijs B, et al. Among authors: crijns hj. Int J Cardiol. 2012 Apr 5;156(1):121-2. doi: 10.1016/j.ijcard.2012.01.024. Epub 2012 Feb 2. Int J Cardiol. 2012. PMID: 22305816 No abstract available.

2

Lone or idiopathic atrial fibrillation, messenger of misery in sight.

Weijs B, Crijns HJ. Weijs B, et al. Among authors: crijns hj. Int J Cardiol. 2014 Dec 20;177(3):734-5. doi: 10.1016/j.ijcard.2014.09.181. Epub 2014 Oct 5. Int J Cardiol. 2014. PMID: 25449498

3

Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation.

De Vos CB, Weijs B, Crijns HJ, Cheriex EC, Palmans A, Habets J, Prins MH, Pisters R, Nieuwlaat R, Tieleman RG. De Vos CB, et al. Among authors: crijns hj. Heart. 2009 May;95(10):835-40. doi: 10.1136/hrt.2008.148528. Epub 2008 Dec 15. Heart. 2009. PMID: 19074923

4

The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation.

Weijs B, de Vos CB, Tieleman RG, Peeters FE, Limantoro I, Kroon AA, Cheriex EC, Pisters R, Crijns HJ. Weijs B, et al. Among authors: crijns hj. Europace. 2013 Jan;15(1):18-23. doi: 10.1093/europace/eus203. Epub 2012 Jul 10. Europace. 2013. PMID: 22782972

5

No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

Folkeringa RJ, de Vos C, Pinto YM, Habets J, De Leeuw PW, Tieleman RG, Prins MH, Van Dieijen-Visser M, Crijns HJ. Folkeringa RJ, et al. Among authors: crijns hj. Int J Cardiol. 2010 Nov 5;145(1):156-8. doi: 10.1016/j.ijcard.2009.07.023. Epub 2009 Aug 26. Int J Cardiol. 2010. PMID: 19712983 Clinical Trial.

6

Pathophysiology of idiopathic atrial fibrillation - prognostic and treatment implications.

Weijs B, Schotten U, Crijns HJ. Weijs B, et al. Among authors: crijns hj. Curr Pharm Des. 2015;21(5):551-72. doi: 10.2174/1381612820666140825150057. Curr Pharm Des. 2015. PMID: 25175085 Review.

7

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study.

Weijs B, Dudink EAMP, de Vos CB, Limantoro I, Tieleman RG, Pisters R, Cheriex EC, Luermans JGLM, Crijns HJGM. Weijs B, et al. Neth Heart J. 2019 Oct;27(10):487-497. doi: 10.1007/s12471-019-1272-z. Neth Heart J. 2019. PMID: 30953281 Free PMC article.

8

Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone.

Tieleman RG, Gosselink AT, Crijns HJ, van Gelder IC, van den Berg MP, de Kam PJ, van Gilst WH, Lie KI. Tieleman RG, et al. Among authors: crijns hj. Am J Cardiol. 1997 Jan 1;79(1):53-7. doi: 10.1016/s0002-9149(96)00675-3. Am J Cardiol. 1997. PMID: 9024736

9

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

Tieleman RG, Van Gelder IC, Crijns HJ, De Kam PJ, Van Den Berg MP, Haaksma J, Van Der Woude HJ, Allessie MA. Tieleman RG, et al. Among authors: crijns hj. J Am Coll Cardiol. 1998 Jan;31(1):167-73. doi: 10.1016/s0735-1097(97)00455-5. J Am Coll Cardiol. 1998. PMID: 9426036 Free article.

10

The 'second factor' of tachycardia-induced atrial remodeling.

Tieleman RG, Crijns HJ. Tieleman RG, et al. Among authors: crijns hj. Cardiovasc Res. 2000 Jun;46(3):364-6. doi: 10.1016/s0008-6363(00)00067-5. Cardiovasc Res. 2000. PMID: 10912446 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

805 results

Search Page